国际标准期刊号: 2469-9764

工业化学:开放获取

开放获取

我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

索引于
  • 哥白尼索引
  • 谷歌学术
  • 参考搜索
  • 研究期刊索引目录 (DRJI)
  • 哈姆达大学
  • 亚利桑那州EBSCO
  • OCLC-世界猫
  • 学者指导
  • 日内瓦医学教育与研究基金会
  • 欧洲酒吧
分享此页面

抽象的

Advancing Industrial Chemistry: Exploring the Bioassay and Efficacy of Micronized Fluconazole against Candida albicans and Aspergillus nige

Radhey Srivastava

C. albicans and Aspergillus fumigatus are the two most frequent fungi that cause severe, undetectable infections in impaired persons. Fluconazole is a highly bioavailable antifungal medication of the triazole class. This study uses Aspergillus fumigatus and Candida albicans to examine the biological effects of fluconazole in both its natural form and as a micronized powder. Using the Microniser, an antifungal active medicinal component was reduced to its tiniest feasible particle size. The antifungal effectiveness of the product was contrasted between the plain material (heavy molecules, 200 microns in diameter), and smaller molecules, 2.72 microns in diameter. Antifungal drugs work best when the particles are the tiniest. The properties and particle size of the micronized material (extremely fine powder) are studied by SEM, Fourier transform infrared spectroscopy (FT-IR), and laser diffraction. The antifungal activity of micronized fluconazole is more effective than that of fluconazole plain material (coarser type particles).